We report our initial experience with percutaneous transvenous closure of atrial septal defects ASD . Materials and Method Between September 1997 and May 2000, we attempted transcatheter closure of ASD in 18 patients using CardioSEALTM 8 , STARFlexTM 4 and Amplatzer septal occluder 6 . The ages of patients ranged from 4.5 64.8 mean 32.8 years, with body weight ranging from 16 76 mean 51 kg, Qp/Qs ratio from 1.3 3.4 mean 2.2 . Results Embolization of the device occurred in two patients right pulmonary artery in one and left atrium in the other. In one patient, the device slipped into the right atrium before detachment. After retrieval of the device, the defect was thought to be too large for transcatheter closure. There were no other complications apart from a transient aggravation of pre-existing atrial premature beats in two patients. There was no significant size difference observed between the data measured by transthoracic and transesophageal echocardiography. The stretched ASD diameter was larger 5.1 3.2 mm than the size measured by transesophageal echocardiography. In the remaining 15 patients, complete closure of the defects was confirmed by transthoracic echocardiography on the 1-day or 1-month follow-up. During the same period, transcatheter closure of the patent foramen ovale PFO was also attempted in 7 stroke patients. The guidewire could not be passed in 2 of the patients. In the other 5 patients, transcatheter closure was successfully performed without any problems. Though the follow-up period may have been short, no patients demonstrated further stroke attack. Conclusion Transcatheter closure of ASD can be performed with high efficiency and safety if patient selection criteria is adequate. The indication for ASD closure can be extended to patients with larger defects. Transcatheter closure of PFO is an easy and safe procedure, although the indications of PFO closure in patients with stroke remain unclear. Further evaluation is required to discern the long-term results. Korean Circulation J 2001 ; 31 6 : 576-583 KEY WORDS Transcatheter closure·Atrial septal defect ASD ·Patent foramen ovale PFO ·Stroke.
The atrial septal defect ASD closure procedure with CardioSEAL TM device. A The device is fully compressed within the sheath. B Holding the delivery system steady, withdraw the sheath off of the left atrial arms of the occluder until the left atrial arms fully deploy. C If the left atrial side position is satisfactory, confirm that the tips of the right atrial arms still collapsed in the sheath are in the right atrium. Then, retract the sheath off of the right atrial arms, allowing the right atrial arms to fully deploy. D After the position is secured, detach the device and slowly withdraw the delivery system from the occluder until full clearance is achieved. 
